Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.
Pollo-Flores, Priscila
Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial. [electronic resource] - Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Nov 2015 - 957-63 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1878-3562
10.1016/j.dld.2015.07.156 doi
Aged
Double-Blind Method
Endosonography
Esophageal and Gastric Varices--etiology
Female
Gastrointestinal Hemorrhage--etiology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypertension, Portal--drug therapy
Liver Cirrhosis--complications
Male
Middle Aged
Portal Pressure
Simvastatin--therapeutic use
Treatment Outcome
Ultrasonography, Doppler, Color
Venous Pressure
Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial. [electronic resource] - Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Nov 2015 - 957-63 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1878-3562
10.1016/j.dld.2015.07.156 doi
Aged
Double-Blind Method
Endosonography
Esophageal and Gastric Varices--etiology
Female
Gastrointestinal Hemorrhage--etiology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypertension, Portal--drug therapy
Liver Cirrhosis--complications
Male
Middle Aged
Portal Pressure
Simvastatin--therapeutic use
Treatment Outcome
Ultrasonography, Doppler, Color
Venous Pressure